Satsuma Pharmaceuticals Inc is a development-stage biopharmaceutical company that develops novel treatments for migraine and other debilitating conditions
Satsuma Pharmaceuticals Inc is a development-stage biopharmaceutical company that develops novel treatments for migraine and other debilitating conditions. The company's lead drug candidate STS101 is a drug-device combination designed for self-administration targeting migraine.